AAAAAA
Results: 1-25/41
Authors:
MARTIN KJ
KWAN CP
NAGASAKI K
ZHANG XH
OHARE MJ
KAELIN CM
BURGESON RE
PARDEE AB
SAGER R
Citation: Kj. Martin et al., DOWN-REGULATION OF LAMININ-5 IN BREAST-CARCINOMA CELLS, Molecular medicine (Cambridge, Mass.), 4(9), 1998, pp. 602-613
Authors:
MARTIN KJ
KWAN CP
OHARE MJ
PARDEE AB
SAGER R
Citation: Kj. Martin et al., IDENTIFICATION AND VERIFICATION OF DIFFERENTIAL DISPLAY CDNAS USING GENE-SPECIFIC PRIMERS AND HYBRIDIZATION ARRAYS, BioTechniques, 24(6), 1998, pp. 1018
Authors:
ZHANG M
MARTIN KJ
SHENG SJ
SAGER R
Citation: M. Zhang et al., EXPRESSION GENETICS - A DIFFERENT APPROACH TO CANCER-DIAGNOSIS AND PROGNOSIS (VOL 16, PG 66, 1998), Trends in biotechnology, 16(3), 1998, pp. 146-146
Authors:
ZHANG M
MARTIN KJ
SHENG SJ
SAGER R
Citation: M. Zhang et al., EXPRESSION GENETICS - A DIFFERENT APPROACH TO CANCER-DIAGNOSIS AND PROGNOSIS, Trends in biotechnology, 16(2), 1998, pp. 66-71
Authors:
SHENG SJ
TRUONG B
FREDRICKSON D
WU RL
PARDEE AB
SAGER R
Citation: Sj. Sheng et al., TISSUE-TYPE PLASMINOGEN-ACTIVATOR IS A TARGET OF THE TUMOR-SUPPRESSORGENE MASPIN, Proceedings of the National Academy of Sciences of the United Statesof America, 95(2), 1998, pp. 499-504
Authors:
ZHANG M
SHENG SJ
MAASS N
SAGER R
Citation: M. Zhang et al., MMASPIN - THE MOUSE HOMOLOG OF A HUMAN TUMOR-SUPPRESSOR GENE INHIBITSMAMMARY-TUMOR INVASION AND MOTILITY, Molecular medicine, 3(1), 1997, pp. 49-59
Authors:
MALEK A
SAGER R
LANG AB
SCHNEIDER H
Citation: A. Malek et al., PROTEIN-TRANSPORT ACROSS THE IN-VITRO PERFUSED HUMAN PLACENTA, American journal of reproductive immunology [1989], 38(4), 1997, pp. 263-271
Authors:
ZHANG M
MAASS N
MAGIT D
SAGER R
Citation: M. Zhang et al., TRANSACTIVATION THROUGH ETS AND AP1 TRANSCRIPTION SITES DETERMINES THE EXPRESSION OF THE TUMOR-SUPPRESSING GENE MASPIN, Cell growth & differentiation, 8(2), 1997, pp. 179-186
Authors:
MAASS N
NAGASAKI K
ZHANG M
SAGER R
JONAT W
Citation: N. Maass et al., TRANSCRIPTIONAL REGULATION OF PROTEASE-INHIBITOR MASPIN WITH TUMOR SUPPRESSOR-ACTIVITY IN BREAST-CANCER, European journal of cancer, 33, 1997, pp. 13-13
Authors:
MARTIN KJ
SAGER R
Citation: Kj. Martin et R. Sager, EXPRESSION GENETICS IN CANCER-RESEARCH, PROGNOSIS, AND THERAPY, Cancer gene therapy, 4(5), 1997, pp. 295-295
Authors:
MAASS N
ZHANG M
SAGER R
JONAT W
Citation: N. Maass et al., TRANSCRIPTIONAL REGULATION OF PROTEASE-INHIBITOR MASPIN IN BREAST EPITHELIAL-CELL AND BREAST CANCER-CELL LINES, Tumordiagnostik & Therapie, 18(4), 1997, pp. 89-96
Authors:
STENMAN G
ASTROM AK
ROIJER E
SOTIROPOULOU G
ZHANG M
SAGER R
Citation: G. Stenman et al., ASSIGNMENT OF A NOVEL CYSTEINE PROTEINASE-INHIBITOR (CST6) TO 11Q13 BY FLUORESCENCE IN-SITU HYBRIDIZATION, Cytogenetics and cell genetics, 76(1-2), 1997, pp. 45-46
Authors:
MALEK A
SAGER R
SCHNEIDER H
Citation: A. Malek et al., TRANSPLACENTAL TRANSPORT OF AMINO-ACIDS AND INFLUENCE OF IGF-I ON THEHUMAN PLACENTAL FUNCTION IN-VITRO, Pflugers Archiv, 433(6), 1997, pp. 691-691
Authors:
SAGER R
Citation: R. Sager, EXPRESSION GENETICS IN CANCER - SHIFTING THE FOCUS FROM DNA TO RNA, Proceedings of the National Academy of Sciences of the United Statesof America, 94(3), 1997, pp. 952-955
Authors:
ZHANG M
MAGIT D
SAGER R
Citation: M. Zhang et al., EXPRESSION OF MASPIN IN PROSTATE CELLS IS REGULATED BY A POSITIVE ETSELEMENT AND A NEGATIVE HORMONAL RESPONSIVE ELEMENT SITE RECOGNIZED BYANDROGEN RECEPTOR, Proceedings of the National Academy of Sciences of the United Statesof America, 94(11), 1997, pp. 5673-5678
Authors:
GOULART R
PRIOLEAU J
SAGER R
SCHNITT S
Citation: R. Goulart et al., MASPIN PROTEIN EXPRESSION IN PREINVASIVE BREAST-LESIONS, Laboratory investigation, 76(1), 1997, pp. 93-93
Authors:
SOTIROPOULOU G
ANISOWICZ A
SAGER R
Citation: G. Sotiropoulou et al., IDENTIFICATION, CLONING, AND CHARACTERIZATION OF CYSTATIN-M, A NOVEL CYSTEINE PROTEINASE-INHIBITOR, DOWN-REGULATED IN BREAST-CANCER, The Journal of biological chemistry, 272(2), 1997, pp. 903-910
Authors:
ZHANG M
MAGIT D
PARDEE AB
SAGER R
Citation: M. Zhang et al., REEXPRESSION OF ELAFIN IN 21MT2 BREAST CARCINOMAS BY PHORBOL 12-MYRISTATE 13-ACETATE IS MEDIATED BY THE AP1 SITE IN THE ELAFIN PROMOTER, Cancer research, 57(20), 1997, pp. 4631-4636
Authors:
ANISOWICZ A
SOTIROPOULOU G
STENMAN G
MOK SC
SAGER R
Citation: A. Anisowicz et al., A NOVEL PROTEASE HOMOLOG DIFFERENTIALLY EXPRESSED IN BREAST AND OVARIAN-CANCER, Molecular medicine, 2(5), 1996, pp. 624-636
Authors:
LUCKHARDT M
LEISER R
KINGDOM J
MALEK A
SAGER R
KAISIG C
SCHNEIDER H
Citation: M. Luckhardt et al., EFFECT OF PHYSIOLOGICAL PERFUSION-FIXATION ON THE MORPHOMETRICALLY EVALUATED DIMENSIONS OF THE TERM PLACENTAL COTYLEDON, Journal of the Society for Gynecologic Investigation, 3(4), 1996, pp. 166-171
Authors:
MALEK A
SAGER R
ALTERMATT HJ
GAENG D
LEISER R
SCHNEIDER H
Citation: A. Malek et al., GLUCOSE CONSUMPTION AND LACTATE PRODUCTION OF HUMAN PLACENTAL TISSUE UNDER DIFFERENT CONDITIONS OF IN-VITRO INCUBATION, Journal of the Society for Gynecologic Investigation, 3(3), 1996, pp. 113-120
Authors:
MALEK A
SAGER R
KUHN P
NICOLAIDES KH
SCHNEIDER H
Citation: A. Malek et al., EVOLUTION OF MATERNOFETAL TRANSPORT OF IMMUNOGLOBULINS DURING HUMAN-PREGNANCY, American journal of reproductive immunology [1989], 36(5), 1996, pp. 248-255
Authors:
HIRSCHI KK
XU CE
TSUKAMOTO T
SAGER R
Citation: Kk. Hirschi et al., GAP JUNCTION GENES CX26 AND CX43 INDIVIDUALLY SUPPRESS THE CANCER PHENOTYPE OF HUMAN MAMMARY-CARCINOMA CELLS AND RESTORE DIFFERENTIATION POTENTIAL, Cell growth & differentiation, 7(7), 1996, pp. 861-870
Authors:
SHENG S
CAREY J
SEFTOR EA
DIAS L
HENDRIX MJC
SAGER R
Citation: S. Sheng et al., MASPIN ACTS AT THE CELL-MEMBRANE TO INHIBIT INVASION AND MOTILITY OF MAMMARY AND PROSTATIC-CANCER CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 93(21), 1996, pp. 11669-11674
Authors:
CHEN ZH
SAGER R
Citation: Zh. Chen et R. Sager, DIFFERENTIAL EXPRESSION OF HUMAN TISSUE FACTOR IN NORMAL MAMMARY EPITHELIAL-CELLS AND IN CARCINOMAS, Molecular medicine, 1(2), 1995, pp. 153-160